Parul University Digital Repository

Development and validation of analytical methods for simultaneous estimation of febuxostat and diclofenac potassium in bulk and in its tablet dosage form

Show simple item record

dc.contributor.author Baria, Hardiksinh
dc.date.accessioned 2020-11-09T09:35:12Z
dc.date.available 2020-11-09T09:35:12Z
dc.date.issued 2013-05-01
dc.identifier.uri http://ir.paruluniversity.ac.in:8080/xmlui/handle/123456789/7486
dc.description For Full Thesis Kindly contact to respective Library en_US
dc.description.abstract The present work involves the development and validation of a simple, accurate and precise Simultaneous Equation Method UV-spectroscopy and RP-HPLC Method for the assay of Febuxostat and Diclofenac Potassium. Simple, specific, accurate, precise and reproducible method have been developed and validated for the simultaneous estimation of both drugs in their combined dosage form. UV- SPECTROPHOTOMETRIC METHOD was a determination using the Simultaneous Equation Method UV-spectroscopy at 314 nm and 277nm over the concentration range 4-14 μg/ml for Febuxostat and 10-35 μg/ml for Diclfoenac Potassium in 0.1 N NaOH respectively. The % recoveries of the both the drugs (in sample preparation) were found to be 100.67-101.5 % for Febuxostat and 100.15-101.9 % for Diclofenac Potassium respectively. The % recoveries of the both the drugs (in bulk preparation) were found to be 99.87-100.83 % and 99.84-100.67% respectively. THE RP-HPLC METHOD has shown adequate separation of Febuxostat And Diclofenac Potassium in bulk and it’s tablet dosage Form. The separation was achieved on a Enable C18 (250mm X 4.6 mm i.d., 5 μm particle size) with a gradient system of ACN: Methanol: water (30:30:40) pH 5 adjusted with O-phosphoric acid and TEA. The mobile phase at a flow rate of 1.0 ml/min, Injection volume 20μl and wavelength of detection used was 280 nm. The retention time Febuxostat and Diclofenac Potassium for was obtained as 3.0±0.1min and 4.4±0.1min, respectively. The linearity of the proposed method was investigated in the range of 4-24 μg/ml and 10-60 μg/ml for Febuxostat and Diclofenac Potassium, respectively. Correlation coefficient was 0.998 and 0.998 for Febuxostat and Diclofenac Potassium Respectively. The developed method was validated as per ICH guideline, for its accuracy, precision, LOD & LOQ and the results were found to be satisfactory, thus the method is specific, rapid and simple with good sensitivity for estimation of Febuxostat and Diclofenac Potassium. These analytical methods are also applicable in ordinary laboratories. It can also be adopted for quality control tests for these drugs in tablets. en_US
dc.language.iso en en_US
dc.publisher Parul University en_US
dc.subject 112140813021 en_US
dc.title Development and validation of analytical methods for simultaneous estimation of febuxostat and diclofenac potassium in bulk and in its tablet dosage form en_US
dc.title.alternative 112140813021 en_US
dc.type Thesis en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account